Dade Behring Marburg GmbH
Records under this name other than patents Dade Behring Marburg GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Dade Behring Marburg GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,242,238 | Surface protein (HBsAg) variant of the hepatitis B virus Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,071,723 | Stable D-dimer liquid preparation Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,094,848 | Pipetting apparatus and methods for an automatic analysis device Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,795,403 | Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof Formerly held Term ended Term ended Oct 14, 2026 · USPTO record | Term ended | Term ended Oct 14, 2026 | USPTO record |
| US 8,409,815 | sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases Formerly held Term ended Term ended May 10, 2026 · USPTO record | Term ended | Term ended May 10, 2026 | USPTO record |
| US 8,399,209 | Homogeneous detection method Formerly held Term ended Term ended May 21, 2025 · USPTO record | Term ended | Term ended May 21, 2025 | USPTO record |
| US 7,276,376 | Analyzing Method of a Blood Coagulation Reaction Formerly held Term ended Term ended Sep 27, 2024 · High confidence | Term ended | Term ended Sep 27, 2024 | High confidence |
| US 9,453,071 | Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof Formerly held Lapsed on the fee record Ended Sep 27, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 27, 2024 | USPTO record |
| US 7,635,571 | Amplified signal in binding assays Formerly held Term ended Term ended Jul 20, 2024 · USPTO record | Term ended | Term ended Jul 20, 2024 | USPTO record |
| US 7,485,312 | Surface protein (HBsAg) variant of the hepatitis B virus Formerly held Term ended Term ended Jun 17, 2024 · USPTO record | Term ended | Term ended Jun 17, 2024 | USPTO record |